United Therapeutics (UTHR) Enterprise Value (2009 - 2026)
United Therapeutics (UTHR) posted Enterprise Value of -$2.2 billion for Q1 2026, up 26.25% sequentially from -$2.9 billion in Q4 2025, and up 35.15% YoY from -$1.6 billion in Q1 2025.
United Therapeutics (UTHR) Enterprise Value (2009 - 2026) Analysis & Trends
United Therapeutics has reported Enterprise Value for 18 years, with the latest figure at -$2.2 billion in Q1 2026.
- Quarterly Enterprise Value rose 35.15% year-over-year to -$2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 billion (up 35.15% YoY) and the FY2025 annual result came in at -$2.9 billion, up 10.61% from the prior year.
- Enterprise Value improved to -$2.2 billion in Q1 2026 per UTHR's latest filing, from -$2.9 billion in the prior quarter.
- Over five years, Enterprise Value peaked at -$2.2 billion in Q1 2026 and troughed at -$3.3 billion in Q3 2024.
- A 5-year average of -$2.8 billion and a median of -$2.9 billion in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2026: Enterprise Value sank 47.03% in 2022, then soared 35.15% in 2026.
- Over 5 years, Enterprise Value stood at -$2.8 billion in 2022, then fell by 5.47% to -$3.0 billion in 2023, then retreated by 9.11% to -$3.3 billion in 2024, then climbed by 10.61% to -$2.9 billion in 2025, then rose by 26.25% to -$2.2 billion in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$2.2 billion, -$2.9 billion, and -$2.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | -656.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.66 Bn |
| Mar 31, 2026 | -2.15 Bn |
| Dec 31, 2025 | -2.92 Bn |
| Sep 30, 2025 | -2.77 Bn |
| Jun 30, 2025 | -3.05 Bn |
| Mar 31, 2025 | -3.32 Bn |
| Dec 31, 2024 | -3.27 Bn |
| Sep 30, 2024 | -3.33 Bn |
| Jun 30, 2024 | -2.97 Bn |
| Mar 31, 2024 | -2.71 Bn |
| Dec 31, 2023 | -2.99 Bn |
| Sep 30, 2023 | -2.88 Bn |
| Jun 30, 2023 | -2.68 Bn |
| Mar 31, 2023 | -2.86 Bn |
| Dec 31, 2022 | -2.84 Bn |
| Sep 30, 2022 | -2.62 Bn |
| Jun 30, 2022 | -2.26 Bn |
| Mar 31, 2022 | -2.27 Bn |
| Dec 31, 2021 | -1.93 Bn |
| Sep 30, 2021 | -2.00 Bn |